Quick Takeaways
- SUSQUEHANNA SECURITIES, LLC filed SCHEDULE 13G/A for Nektar Therapeutics Common Stock, $0.0001 par value per share (NKTR).
- Disclosed ownership: 4%.
- Date of event: 31 Dec 2025.
SUSQUEHANNA SECURITIES, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Nektar Therapeutics Common Stock, $0.0001 par value per share (NKTR)
- Filing Manager
- SUSQUEHANNA SECURITIES, LLC
- Reporting Manager
- G1 Execution Services, LLC
- Symbol
- NKTR
- Shares outstanding
- 20,249,175 shares
- Disclosed Ownership
- 809,967 shares
- Ownership
- 4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Feb 2026, 17:17:56 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 13 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"SUSQUEHANNA SECURITIES, LLC disclosed 4% ownership in Nektar Therapeutics Common Stock, $0.0001 par value per share (NKTR) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 13 Nov 2025.
- Current filing was accepted on 13 Feb 2026, 17:17.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| G1 Execution Services, LLC | 4% | 809,967 | 8,773 | 809,967 | /s/ Brian Sopinsky | Brian Sopinsky, Secretary | |
| Susquehanna Portfolio Strategies, LLC | 4% | 809,967 | 16,057 | 809,967 | /s/ Brian Sopinsky | Brian Sopinsky, Assistant Secretary | |
| Susquehanna Securities, LLC | 4% | 809,967 | 785,137 | 809,967 | /s/ Brian Sopinsky | Brian Sopinsky, Secretary |